In December 2022, Carl-Johan Ivarsson, CEO of Qlucore, was interviewed by Oscar Dahlgran, CEO of Västra Hamnen Corporate Finance. Listen to the conversation about Qlucore's unique analysis platform and the eventful autumn and winter.

Interview with QLUCORE CEO Carl-Johan Ivarsson where he talks about

- What the company does

- Why an investor should look at Qlucore right now

- The most important issues for 2023 - The revenue target of 300 MSEK in 2027

Read our full research on QLUCORE at https://www.emergers.se/bolag_qlucore

(Interview held in swedish).

In December 2022, Carl-Johan Ivarsson, CEO of Qlucore, was interviewed by Oscar Dahlgran, CEO of Västra Hamnen Corporate Finance. Listen to the conversation about Qlucore's unique analysis platform and the eventful autumn and winter.

(Interview held in swedish).

On March 31, Qlucore participated in the Redeye Theme Digital Health Day. CEO, Carl-Johan Ivarsson, presented the company and participated in the panel discussion afterwards. Starts at 25:50 minutes in the video.

Redeye is an analysis-driven corporate finance company with a conviction that Scandinavia will be a hub for the major future innovations in tech and life science. (Presentation held in english).

Den 9 mars 2022 deltog Qlucore på Stockholm Corporate Finance 14e Life Science Kapitalmarknadsdagar. VD Carl-Johan Ivarsson presenterade Qlucore och svarade på frågor om bolaget.

Stockholm Corporate Finance arrangerar kapitalmarknadsdagarna för fjortonde året i rad i samarbete med Financial Hearings och Nyhetsbyrån Direkt. (Presentation på svenska).

Se presentation här

Presentation kring Qlucores satsning inom klinisk diagnostik.

Den 31 januari medverkade Qlucore på Aktiespararnas evenemang Digitala Aktiekvällen. VD Carl-Johan Ivarsson presenterade Qlucore och svarade på frågor om bolaget. (Presentation på svenska).

Den 19 januari deltag Qlucore på Emergers Bolagsträff. VD Carl-Johan Ivarsson presenterade Qlucore och satsningen inom klinisk diagnostik. (Presentation på svenska)